CompletedNot Applicable

Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children

United States11,760 participantsStarted 2022-05-13

Plain-language summary

This study's objective is to identify and test pragmatic and sustainable strategies for implementing a multi-condition clinical pathway intervention for children hospitalized with asthma, pneumonia, or bronchiolitis in community hospitals. The hypothesis is that the multi-condition pathway intervention will be associated with significantly greater increases in clinicians' adoption of evidence-based practices compared to control. The study is a pragmatic, cluster-randomized trial in US community hospitals. The primary outcome will be adoption of evidence-based practices over a sustained period of 2 years. Secondary outcomes include length of hospital stay, intensive care unit transfer, and hospital readmission/emergency department revisit.

Who can participate

Age range

17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primary diagnosis of asthma AND age \>2 to \<18 years-old at time of admission to the hospital OR * Primary diagnosis of pneumonia AND age \>2 months and \<18 years at time of admission to the hospital OR * Primary diagnosis of bronchiolitis AND age \<2 years at time of admission to the hospital Exclusion Criteria: * Diagnosis of SARS-CoV-2 * Transfer in from another inpatient facility * Pre-existing chronic illnesses (e.g., lung disease, cardiovascular disease, neurologic disorders)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Pneumonia Evidence Based Practice 1

Timeframe: During a hospitalization, approximately 2 days

Pneumonia Evidence Based Practice 2

Timeframe: During a hospitalization, approximately 2 days

Asthma Evidence Based Practice 1

Timeframe: During a hospitalization, approximately 2 days

Asthma Evidence Based Practice 2

Timeframe: During a hospitalization, approximately 2 days

Asthma Evidence Based Practice 3

Timeframe: During a hospitalization, approximately 2 days

Bronchiolitis Evidence Based Practice 1

Timeframe: During a hospitalization, approximately 2 days

Bronchiolitis Evidence Based Practice 2

Timeframe: During a hospitalization, approximately 2 days

Trial details

NCT IDNCT05206695

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-21

View on ClinicalTrials.gov More Asthma trials

Plain-language summary

Who can participate

Age range

17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Pneumonia Evidence Based Practice 1

Timeframe: During a hospitalization, approximately 2 days

Pneumonia Evidence Based Practice 2

Timeframe: During a hospitalization, approximately 2 days

Asthma Evidence Based Practice 1

Timeframe: During a hospitalization, approximately 2 days

Asthma Evidence Based Practice 2

Timeframe: During a hospitalization, approximately 2 days

Asthma Evidence Based Practice 3

Timeframe: During a hospitalization, approximately 2 days

Bronchiolitis Evidence Based Practice 1

Timeframe: During a hospitalization, approximately 2 days

Bronchiolitis Evidence Based Practice 2

Timeframe: During a hospitalization, approximately 2 days